3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
57
Pancreatic Neoplasms
39
Carcinoma, Non-Small-Cell Lung
29
Triple Negative Breast Neoplasms
20
Neoplasms
17
Neoplasm Metastasis
11
Lung Neoplasms
10
Squamous Cell Carcinoma of Head and Neck
9
Ovarian Neoplasms
8
Melanoma
7
Head and Neck Neoplasms
6
Breast Neoplasms, Male
6
Adenocarcinoma
6
Urinary Bladder Neoplasms
5
Inflammatory Breast Neoplasms
5
Carcinoma
5
Sarcoma
4
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Pancreatic Diseases
4
Fallopian Tube Neoplasms
4
Cholangiocarcinoma
4
Carcinoma, Ovarian Epithelial
4
Stomach Neoplasms
3
Small Cell Lung Carcinoma
3
Pancreatic Adenocarcinoma
3
Esophageal Neoplasms
3
Endocrine System Diseases
3
Endocrine Gland Neoplasms
3
Digestive System Neoplasms
3
Digestive System Diseases
3
Interventions
selpercatinib
2
pralsetinib
2
pembrolizumab
2
Pemetrexed
2
Paclitaxel
2
Carboplatin
2
patritumab
1
osimertinib
1
napabucasin
1
efineptakin alfa
1
durvalumab
1
cobimetinib
1
atezolizumab
1
alectinib
1
Tyrosine Kinase Inhibitors
1
Radiosurgery
1
Proton Therapy
1
Metformin
1
Gemcitabine
1
Erlotinib Hydrochloride
1
Dasatinib
1
Cisplatin
1
Bevacizumab
1
Afatinib
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Thoracic Neoplasms
×
Albumin-Bound Paclitaxel
×
Clear all
No trials found.